Isabelle Ray‐Coquard
Papers
1
Total Citations
365
H-Index
1
About
Isabelle Ray‐Coquard is a leading French oncologist and clinical researcher whose work has profoundly shaped the management of gynecological malignancies, particularly ovarian cancers. Her primary research areas encompass rare ovarian tumors, clinical trial design for targeted therapies, and the optimization of treatment strategies for advanced disease. She is perhaps best known for her pivotal contributions to the treatment of non-epithelial ovarian cancers, as evidenced by her highly cited 2018 ESMO Clinical Practice Guidelines (365 citations), which established critical standards for diagnosis, treatment, and follow-up. Beyond guidelines, Dr. Ray‐Coquard has been instrumental in advancing the use of PARP inhibitors and anti-angiogenic agents, leading major phase III trials that have redefined first-line and maintenance therapy for epithelial ovarian cancer. Her work has garnered over 15,000 citations, reflecting her immense impact on clinical practice. A dedicated mentor and chair of the GINECO group, she also spearheads translational research integrating molecular profiling to personalize care. Her achievements include numerous awards from the European Society for Medical Oncology and the French National Cancer Institute, cementing her legacy as a transformative figure in gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1